The demographic of the world's population is shifting towards older age groups. The prevalence of falls and associated injuries and morbidity is on the rise, posing a significant global challenge. Knowing the causes of falls in elderly can help create awareness and aid prevention. Let’s find out a bit more about the causes of falls in elderly.
Professor Bernard Isaacs, a giant in geriatric medicine said, ‘It takes a child one year to acquire independent movement and ten years to acquire…
Tofacitinib (Xeljanz®) is the first of a unique class of oral kinase inhibitors to be FDA approved for the treatment of rheumatoid arthritis (RA). Tofacitinib is a selective inhibitor of Janus kinase (JAK) enzymes. these enzymes mediate signaling for several important cytokines that cause the inflammation in Rheumatoid Arthritic patients.
Condition